Skip to main content
Download PDF

Neuroimaging studies of acupuncture on Alzheimer’s disease: a systematic review

BMC Complementary Medicine and Therapies volume 23, Article number: 63 (2023) Cite this article

Abstract

Background

Acupuncture effectively improves cognitive function in Alzheimer’s disease (AD). Many neuroimaging studies have found significant brain alterations after acupuncture treatment of AD, but the underlying central modulation mechanism is unclear.

Objective

This review aims to provide neuroimaging evidence to understand the central mechanisms of acupuncture in patients with AD.

Methods

Relevant neuroimaging studies about acupuncture for AD were retrieved from eight English and Chinese medicine databases (PubMed, Embase, Cochrane Library, Web of Science, SinoMed, CNKI, WF, VIP) and other resources from inception of databases until June 1, 2022, and their methodological quality was assessed using RoB 2.0 and ROBINS - I. Brain neuroimaging information was extracted to investigate the potential neural mechanism of acupuncture for AD. Descriptive statistics were used for data analysis.

Results

Thirteen neuroimaging studies involving 275 participants were included in this review, and the overall methodological quality of included studies was moderate. The approaches applied included task-state functional magnetic resonance imaging (ts-fMRI; n = 9 studies) and rest-state functional magnetic resonance imaging (rs-fMRI; n = 4 studies). All studies focused on the instant effect of acupuncture on the brains of AD participants, including the cingulate gyrus, middle frontal gyrus, and cerebellum, indicating that acupuncture may regulate the default mode, central executive, and frontoparietal networks.

Conclusion

This study provides evidence of the neural mechanisms underlying the effect of acupuncture on AD involving cognitive- and motor-associated networks. However, this evidence is still in the preliminary investigation stage. Large-scale, well-designed, multimodal neuroimaging trials are still required to provide comprehensive insight into the central mechanism underlying the effect of acupuncture on AD. (Systematic review registration at PROSPERO, No. CRD42022331527).

Peer Review reports

Background

Alzheimer’s disease (AD), a progressive neurodegenerative disease, [1,2,3] initially affects cognitive function and progresses to loss of control over activities of daily living, as well as several psychological and behavioral changes [4, 5]. Dementia due to AD prevalence grows exponentially with age [6, 7]. With an annual overall incidence of 12.8–15.8 per 1000 persons, it has been estimated that the dementia population will rise to 131 million globally by 2050 [8,9,10]. In addition, as the current population ages, the incidence of AD increases, thus increasing the caring and nursing burden [11]. However, due to the complex pathogenesis of AD, no disease-modifying therapy is available [12, 13]; hence, AD is currently one of the most serious global healthcare and economic health concerns.

So far, there is no cure therapy for the whole AD process. Pharmacotherapy, as the current first-line treatment for AD [14], has a persistent role across all AD stages [2, 15]; however, pharmacotherapy may cause bradycardia [16], gastrointestinal disorders [17], and other adverse effects. Consequently, there is an urgent need to investigate non-pharmacological therapies for AD. Acupuncture, a commonly used non-pharmacological method in China, has long been used to treat cognitive dysfunction in China [18,19,20,21]. Numerous systematic reviews/meta-analyses [22,23,24,25] and randomized controlled trials (RCTs) [26, 27] have revealed that acupuncture can be used to treat AD. For instance, Huang et al. [23] found that acupuncture was superior to conventional medicines. Moreover, Zhou et al [25] revealed that acupuncture plus herbal medicine might have advantages over Western drugs, and our previous study [28] illustrated that acupuncture, as a monotherapy or a complementary therapy, is effective against AD.

The effect of acupuncture on AD is widely recognized; however, the underlying mechanisms have not been fully elucidated. Numerous studies have demonstrated that AD is one of the most prevalent central neurodegenerative diseases [29,30,31]. Brain imaging alterations have been considered the underlying pathological targets in AD [32]. Accordingly, it would be valuable to explore the central mechanisms of acupuncture in AD. With the growing number of neuroimaging studies on acupuncture for AD, multiple neuroimaging approaches and various analytical methods offer evidence of the underlying neural mechanism [33,34,35,36,37]. However, no systematic review has revealed the central mechanism in patients with AD. Therefore, this systematic review of neuroimaging studies aimed to evaluate the use of acupuncture in AD treatment to provide evidence for its clinical application and as a reference for future clinical research.

Methods

Study design

This review was registered on the PROSPERO platform (No. CRD42022331527) and improved reporting based on the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement [38] and A Measure Tool to Assess Systematic Reviews-2 (AMSTAR-2) checklist [39].

Inclusion and exclusion criteria

All neuroimaging clinical studies on the use of acupuncture on AD were eligible for inclusion. Conversely, we excluded case reports, comments, and studies with missing neuroimaging data. Patients with only AD with specific criteria (such as the Diagnostic and Statistical Manual of Mental Disorders (DSM), and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria), regardless of age, sex, race, or region, were included. We did not include any studies that enrolled patients diagnosed with other types of dementia or a combination of different types of dementia. Eligible interventions involved manual and electronic acupuncture, regardless of the acupoint, needling technique, treatment duration, and acupuncturist. Control methods comprised healthy control, waitlist, placebo, usual care, and conventional medicine. At least one neuroimaging approach should have been used: functional near-infrared spectroscopy (fNIRS), structural magnetic resonance imaging (sMRI), functional magnetic resonance imaging (fMRI), and positron emission tomography (PET). Since this study aimed to investigate the neuroimaging mechanism of acupuncture for AD, the outcomes were amplitude of low-frequency fluctuations (ALFF), functional connectivity (FC), and cerebral neuron alteration.

Search strategy

Two reviewers independently searched the following sources from inception until June 1, 2022: PubMed, Embase, Cochrane Library, Web of Science (WOS), SinoMed, China National Knowledge Infrastructure (CNKI), WanFang Database, Chinese Scientific Journal Database (VIP), three clinical trial registries (WHO ICTRP (www.who.int/clinical-trials-registry-platform), ChiCTR (www.chictr.org.cn/), Clinical Trials.gov (clinicaltrials.gov)), and Grey Literature Database (www.greylit.org/). The search terms were a combination of Alzheimer’s disease, acupuncture, and neuroimaging-related terms; More detail on the search strategies is provided in Additional file 1.

Study selection and data extraction

Duplicate studies were excluded, and potentially eligible studies were uploaded using NoteExpress V3.0. The titles, abstracts, and keywords were screened according to the inclusion criteria to identify relevant studies. Finally, the reviewers rechecked the full-text neuroimaging studies to determine their eligibility for inclusion.

Two investigators independently extracted information using a self-defined standardized extraction form that covered the identification information (first author, country, and publication date), basic information (study design, sample size, diagnostic standard, age, and sex), details about the intervention and control groups, clinical variables, and neuroimaging findings. The Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) provides precise guidelines for reporting acupuncture interventions, and details on the acupuncture interventions used were collected based on these guidelines. Any disagreements were settled by consultation.

Quality assessment

The Cochrane Handbook was applied to independently assess the risk of bias by two evaluators using the related Excel template (available from www.riskofbias.info/). The methodological quality of the RCTs was assessed based on the risk of bias 2.0 tool (RoB 2) [40]. The tool evaluates the RoB across five domains (randomization process, deviations from the intended interventions, missing data, outcome measurement, and reporting). Subsequently, an overall rating for the RoB was derived for each outcome. And The overall RoB was ranked as high, low, and some concerns. Any disagreements were settled by consultation.

The methodological quality of non-RCTs was evaluated using the risk of bias in non-randomized studies of interventions (ROBINS-I) [41]. This tool evaluates the RoB across seven factors (pre-intervention (bias due to confounding and bias in selection of participants), at-intervention (classification bias), and post-intervention (bias due to intended interventions deviations, missing data, outcome measurement, and reporting)). Subsequently, the overall RoB rating was derived for each outcome. The overall RoB was ranked as critical, serious, moderate, low, or no information.

Statistical analysis

Because of the various analytical approach in the included studies, a descriptive analysis was used for the statistical analysis for the moment. This analysis was conducted to summarize acupuncture-induced brain alterations in patients with AD. The data are presented as counts and frequencies.

Results

Study description

Literature search

From the literature search, we identified 447 potentially eligible trials. After removing any duplicates, 254 studies were included. Next, the titles, abstracts, and keywords of the remaining publications were reviewed against the exclusion criteria, which left 28 potential candidate studies. Finally, after reading the full-text, 15 trials were excluded (four due to not being neuroimaging studies, two with ineligible treatment, seven with ineligible subjects, and two with duplicate content), leaving 13 trials [34,35,36, 42,43,44,45,46,47,48,49,50,51]. The PRISMA flow chart for this review is depicted in Fig. 1, and the reasons why the 15 full-text studies were excluded are listed in Additional file 2.

Fig. 1
figure 1

The PRISMA flow chart of selection process

Full size image

Study characteristics

Table 1 lists the details and main characteristics of the 13 studies included in the current review. The published neuroimaging data were from 2005 to 2021. All of the included studies were performed in China.

Table 1 Main characteristics of included neuroimaging studies
Full size table

Study design

There was one RCT [34,35,36, 42,43,44,45,46,47,48,49,50,51] and 12 non-RCTs (self-control studies) [34,35,36, 42, 44,45,46,47,48,49,50,51] included. Nine studies [34,35,36, 42, 44,45,46,47,48,49,50,51] explored acupuncture-induced brain activation, four studies [34,35,36, 42] investigated acupuncture-induced brain functional networks, and one study [34] evaluated acupuncture-induced brain neuronal activity.

Participants

A total of 154 patients with AD and 121 healthy subjects were included, and all neuroimaging studies applied the NINCDS-ADRDA criteria [52]. Seven studies [34,35,36, 42,43,44, 48] applied DSM [9] and NINCDS-ADRDA criteria. Nine studies [34,35,36, 42, 44, 46,47,48,49] compared patients with AD to healthy subjects. Three studies [45, 50, 51] only enrolled patients with AD, while one trial [45, 50, 51] used a three-group design containing acupuncture, sham acupuncture, and healthy controls. The sample sizes ranged from six to 35, and 275 participants were included in the study. Only one study [43] had a sample size of more than 30. The common matching sample size ratio of AD/health controls was 1:1. The subjects with AD ranged in age from 62 to 80 years, and 12 studies [43] reported AD patient sex (62 males and 76 females). Nine neuroimaging studies [34,35,36, 42, 44,45,46,47, 50] included patients with mild and moderate AD, and one study [48] enrolled patients with mild to severe AD.

Acupuncture

The acupuncture details of the neuroimaging studies were collected and are displayed in Table 2 on account of the STRICTA [53]. The rationale for acupuncture was reported in all of the neuroimaging studies. The subjects had between one to four needle insertions per session, and LR 3 (eight studies, 61.54%) and LI 4 (eight studies, 61.54%) were the commonly applied acupoints. The mean value of the insertion depth was 14.31, and all acupuncture depths were not more than 25 mm. Seven studies described the responses sought. Manual acupuncture was employed in eight studies. Electronic acupuncture was used in five studies, and the electronic acupuncture apparatus used was G6805C. Typically, the needles used in both acupuncture methods were 0.30 mm in diameter and 25 mm long. The studies involved a one treatment session of 3 min. Only two studies provided details of the acupuncturists, and nine reported details of the comparator interventions.

Table 2 Details of acupuncture methods according to Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA)
Full size table

Comparison

The 13 studies that referred to the three comparison models were as follows: acupuncture versus healthy volunteers (n = nine studies), the self-control model (pre- vs. post-treatment, n = three studies), and acupuncture versus sham acupuncture (n = one study).

Clinical variables

Four cognitive assessment approaches were used to evaluate AD: the Montreal Cognitive Assessment Scale (MoCA; three studies), Mini-Mental State Examination (MMSE; three studies), Clinical Dementia Rating (CDR; three studies), and auditory verbal learning test (AVLT; three studies).

Quality assessment

The one RCT included was found to have a moderate RoB using the RoB 2 approach. In the section on the “randomization process” and “selection of the reported results”, the study had some concerns due to unclear random sequence generation and lacking protocol/registration. Of the 12 non-RCTs, the ROBINS-I revealed low methodological quality in five studies and high quality in seven. Four studies had serious risks in the confounding section due to insufficient baseline confounding details (such as cognitive function and education level), whereas seven had a low risk. Regarding missing data, one study had a serious risk due to insufficient details on large sample losses in the follow-up period, while others had a low risk. Notably, all studies had a low RoB in the other sections. The results of the RoB evaluations are presented in Additional files 3 and 4.

Neuroimaging findings of acupuncture for AD

Imaging condition and analysis

Functional magnetic resonance imaging (fMRI) was used to measure functional changes induced by acupuncture, including task-state fMRI (ts-fMRI) and rest-state fMRI (rs-fMRI). ts-fMRI was applied to explore brain functional activation, whereas rs-fMRI was applied to explore brain functional networks using the FC method, and brain neuronal activity using the ALFF.

Acupuncture-related brain activities in fMRI

All studies focused on the instant effect of acupuncture. Rest and task states were the two main study designs used for fMRI. The neuroimaging results after acupuncture are presented in Additional file 5.

Based on the ts-fMRI studies, nine neuroimaging studies [34,35,36, 42] reported that the activated brain areas after acupuncture concerned the processing of cognitive function, including the memory regions (e.g., the hippocampus, inferior frontal gyrus, superior frontal gyrus, and superior temporal gyrus), auditory speech area (e.g., the superior temporal gyrus, transverse temporal gyrus, and inferior parietal lobule), language function region (e.g., the middle frontal gyrus, middle temporal gyrus, and cerebellum), spatial attention region (e.g., the superior parietal lobule), affective-emotional processing areas of cognitive function (e.g., the insula, cingulate cortex, and thalamus), motor function region (e.g., the precentral gyrus), and sensory function region (e.g., the postcentral gyrus).

Regarding the four rs-fMRI studies [34,35,36, 42], one study [34] reported that increased ALFF after acupuncture in the brain area occurred in the postcentral gyrus, and decreased ALFF in the brain area occurred in the inferior frontal gyrus, hippocampus, and cingulate cortex. In addition, using FC analysis, Ji et al. [42] found that the right middle frontal gyrus of the right frontal-parietal network decreased significantly after acupuncture. Conversely, two studies [34, 36] reported increased FC between the hippocampus and middle frontal gyrus/precentral gyrus. Furthermore, one study [35] found an increased connection between cognition-related brain areas, such as the inferior parietal lobule, middle temporal gyrus, and posterior cingulate cortex, with decreased connectivity between the cingulate gyrus and precuneus.

The relationship between the neuroimaging results and clinical outcomes

Furthermore, there was a significant positive correlation between the FC strength of the right middle temporal gyrus and the changed MMSE and MoCA scores [35]. Meanwhile, Zheng et al. [35] found positive correlations between the ALFF of the subgenual cingulate cortex and MMSE and MoCA scores, with negative correlations between the AVLT scores and ALFF of the hippocampus and the right inferior temporal gyrus or FC of the right hippocampus and the left precentral gyrus.

Top ten acupuncture-induced altered brain areas

As demonstrated in Table 3, the top ten acupuncture-related brain alterations in subjects with AD were in the cingulate gyrus (eight studies, 61.54%), middle frontal gyrus (seven studies, 53.85%), cerebellum (seven studies, 53.85%), superior temporal gyrus (six studies, 46.15%), inferior parietal lobule (six studies, 46.15%), superior frontal gyrus (five studies, 38.46%), inferior frontal gyrus (five studies, 38.46%), middle temporal gyrus (five studies, 38.46%), postcentral gyrus (four studies, 30.77%), superior parietal lobule (three studies, 23.08%), precentral gyrus (three studies, 23.08%), and hippocampus (three studies, 23.08%).

Table 3 Top 10 brain areas of acupuncture-related alterations of included neuroimaging studies
Full size table

Potential acupuncture-induced altered brain pathways

The main brain areas could be roughly classified into five pathways (Fig. 2, Additional file 5): the default mode network (DMN; for example, the cingulate gyrus, superior temporal gyrus, superior frontal gyrus, middle temporal gyrus, and hippocampus), central executive network (CEN; for example, the cingulate gyrus, inferior parietal lobule, middle temporal gyrus, and precentral gyrus), frontoparietal network (FPN; for example, the middle frontal gyrus, inferior parietal lobule, superior frontal gyrus, inferior frontal gyrus, superior parietal lobule), dorsal attention network (DAN; for example, the middle temporal gyrus, superior parietal lobule), and the sensorimotor network (SMN; for example, the postcentral gyrus, and precentral gyrus).

Fig. 2
figure 2

The main reported neuroimaging findings by acupuncture. Note. ACG: anterior cingulate and paracingulate gyri; CRBL: cerebellum; HIP: hippocampus; IFG: inferior frontal gyrus; IPL: inferior parietal lobule; MFG: middle frontal gyrus; MTG: middle temporal gyrus; PCG: posterior cingulate gyrus; PoCG: postcentral gyrus; PreCG: precentral gyrus; SFG: superior frontal gyrus; SPL: superior parietal lobule; STG: superior temporal gyrus

Full size image

Discussion

Study characteristics of the acupuncture neuroimaging studies on AD

The included studies aimed to explore whether acupuncture could cause brain activation, alternation of the brain network, and brain neuronal activity. Nine of the 13 neuroimaging studies explored whether acupuncture could cause brain activation. However, there is no consensus regarding these alterations. In addition, four studies investigated whether acupuncture could affect brain functional networks, and one study evaluated acupuncture-induced brain neuronal activity. However, only two studies determined the correlation between acupuncture effects and functional network/neuronal activity.

Based on previous study [54], the sample size may affect the treatment effect evaluation. All included studies had a sample size of less than 30, which may have affected the stability and replicability of the findings; thus, future studies should be conducted with larger sample sizes to confirm the findings of the current review. Additionally, there were more female than male with AD. According to previous studies [55,56,57], sex is a vital feature influencing physiopathological mechanisms and therapies for patients with AD. Nevertheless, no study explored on the sex-disaggregated neural mechanism of acupuncture in AD. Therefore, sex-disaggregated neuroimaging trials are supposed to carry out.

In terms of the acupuncture details, of the included 13 neuroimaging studies, LR 3 (Taichong) and LI 4 (Hegu) LR 3 and LI 4 were the most frequently used acupoints. In traditional Chinese medicine theory, LI 4 and LR 3 are named the Siguan [58]. Siguan points are recommended for future neuroimaging studies on acupuncture interventions in AD. In addition, eight studies adopted manual acupuncture, but only two recorded the details of the acupuncturists. Researchers should pay more attention to acupuncturists [59, 60]. Moreover, the cerebral response is associated with the degree of sensation in neuroimaging; consequently, the response sought should be carefully documented. Finally, based on the STRICTA, several factors may have affected the study findings; therefore, future studies should apply standardized acupuncture procedures based on the STRICTA.

Only three comparison models, acupuncture versus healthy volunteers, self-controlled before and after acupuncture, and acupuncture versus sham acupuncture, were adopted in the included studies. The acupuncture versus healthy volunteer model explores the distinct cerebral activities between patients with AD and healthy people before and after acupuncture, the self-control comparison investigates the alterations in brain areas affected by acupuncture, and acupuncture versus sham acupuncture evaluates the specific cerebral alterations between acupuncture and placebo. However, according to the STRICTA criteria, these models are insufficient for exploring the numerous effects of acupuncture in AD. For instance, according to the STRICTA, the depth, response sought, acupuncture stimulation, practitioners, and other factors affecting acupuncture efficacy require further research.

Regarding the outcome measurements, the cognitive outcome measures applied in the included studies were MMSE, MoCA, CDR, and AVLT, which have been commonly applied to detect cognitive impairment. MMSE and CDR are suggested for evaluating dementia, MoCA is recommended for evaluating mild cognitive impairment (MCI) [61], and AVLT is recommended to measure episodic memory function in AD [62]. However, none of these scales comprehensively assess the cognitive function of patients with AD. The Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), as a gold standard, was developed to assess the level of cognitive dysfunction in AD [63, 64]. Accordingly, it is recommended that ADAS-Cog be used to assess the cognitive function of patients with AD in future studies.

Current methodology of the included studies

Seven of the 13 neuroimaging studies were designated as low risk; five studies were ranked as serious risk; and others were ranked as some concerns about the quality of the methodology used. The one RCT included had some concerns due to issues in the randomization process and selection of the reported results. Of the 12 non-RCTs included, the risk of bias in five studies was serious due to the potential bias of confounding and measurement of the outcomes. Therefore, future studies should strictly conform to the Cochrane Handbook. For instance, according to the Cochrane Handbook, future RCTs should pay more attention to implementing the randomization process and selecting the reported results. Future non-RCTs should provide sufficient details regarding confounding and missing data. Also, due to the unsatisfactory methodological quality, it is suggested that more high quality neuroimaging studies should be conducted to improve the quality and confirm the findings of the current review. In addition, RCTs are considered the gold standard for evaluating the efficacy of interventions; thus, more RCTs are required to confirm that acupuncture protocols employed in neuroimaging studies are effective in AD treatment.

The neuroimaging findings of acupuncture for AD

All of the 13 studies included concentrated solely on brain functional alterations. The neuroimaging method used in the included studies was fMRI. fMRI indirectly measures brain alterations to study the nervous system via hemodynamic and neurovascular coupling [65]. According to previous studies [66,67,68,69], AD is a multidimensional central nervous system disease that affects brain structure and function. Although fMRI is a powerful approach for brain activity analysis, it is not comprehensive enough for neural processing. Numerous neuroimaging techniques have been used to assess neural processing in AD. For instance, diffusion tensor imaging (DTI) is an advanced MRI technique that has been used to provide qualitative and quantitative white matter microarchitecture information of AD [70]. Furthermore, electroencephalography (EEG), the measurement of the brain’s electric fields, has been used in diagnosing, assessing, and monitoring medical treatment in patients with AD [71]. PET, a tool used to quantify physiological processes, has proven useful for diagnosing and predicting AD [72]. It is well known that these approaches have their own characteristics, so integrating multiple approaches allows for a more comprehensive assessment of the effects of acupuncture on AD. Thus, integrating multiple approaches (such as fMRI with DTI, fMRI with EEG, and fMRI with PET) can be a comprehensive way to study acupuncture in AD. Multimodal neuroimaging methods are urgently needed to provide an opportunity to understand the comprehensive neural mechanisms of acupuncture for AD and guide clinical treatment options for patients with AD.

In this review, all of the included studies also explored the instant acupuncture effect, demonstrating that the top ten brain regions affected were the cingulate gyrus, middle frontal gyrus, cerebellum, superior temporal gyrus, inferior parietal lobule, superior frontal gyrus, inferior frontal gyrus, middle temporal gyrus, postcentral gyrus, superior parietal lobule, precentral gyrus, and hippocampus. These brain areas are associated with AD. Accumulating evidence [73, 74] suggests that the cingulate gyrus is a neurodegenerative biomarker for understanding the neural mechanisms of AD. In addition, numerous studies [75,76,77] have reported increased FC in the middle frontal gyrus and other brain regions in AD. Moreover, previous reports [78,79,80,81] have illustrated that the cerebellum contributes to cognitive and neuropsychiatric deficits in AD. Previous studies have revealed that the cortical thickness of the superior temporal gyrus and inferior parietal lobule changes during AD progression [82, 83]. In addition, the superior frontal gyrus and inferior frontal gyrus were positively associated with cognitive function [77, 84]. Moreover, word fluency and naming were correlated with the cortical thickness of the middle temporal gyrus [85]. Valera-Bermejo also found that the postcentral and precentral gyri volumes were correlated with episodic and semantic memory [86]. Accumulating research [87,88,89] has illustrated a change in FC in the superior parietal lobule and other brain regions in AD. Numerous studies have demonstrated that the hippocampus, one of the first structures affected by AD, was regarded as a sensitive neurodegenerative neuroimaging biomarker [90,91,92]. Meanwhile, previous neuroimaging studies [93,94,95,96,97,98] illustrated that adjusting these brain regions is a crucial neural mechanism of acupuncture treatment in cognitive impairment diseases. Since acupuncture can promote neuroplasticity and repair these damaged brain areas [99, 100], the changes in these brain regions are due to an interaction between acupuncture and AD pathology. In addition, the top ten brain areas of most included studies were emerged naturally with data-driven approaches, and only one region (hippocampus) was specifically analysed in a study [36]. Therefore, these brain areas are genuinely changing with acupuncture in AD compared to other regions. Based on the findings, future acupuncture studies should pay more attention to these brain regions.

The included neuroimaging studies of acupuncture for AD showed that instant acupuncture might adjust the brain networks. Significant pathways related to acupuncture for AD in the included studies are displayed. The results showed that the essential regions of DMN, CEN, FPN, DAN, and SMN are included in the brain regions that undergo alterations due to acupuncture for AD. These brain networks are correlated with cognitive and motor function. DMN plays an important role in cognitive function and internally directed thoughts. Moreover, it is closely connected with AD due to its association with AD atrophy modes and tau sedimentation [101,102,103]. CEN is a significant network obsessed with cognitive control and episodic memory [104, 105]. DAN is involved in the externally oriented actions and perceptions [106,107,108]. Numerous studies have demonstrated that altered DMN, CEN, and DAN are prominent biomarkers of AD [109]. FPN was shown to play an outstanding role in executive and language functions [110, 111]. Many studies [110,111,112,113] have illustrated that abnormal FC and compensation in the FPN might coexist in AD. SMN was characterized by a hypoactivation phase in patients with AD [114], while the altered FC of the sensorimotor cortical network was associated with a phenotype conversion from MCI to AD [115]. Previous studies [116, 117] have demonstrated disrupted large-scale resting-state FCs in the above networks in patients with AD. Meanwhile, multiple neuroimaging studies [118,119,120,121,122] have suggested that regulating the alterations of these networks is a vital mechanism of acupuncture treatment. Therefore, cognitive-related and motor-associated brain areas are involved in the acupuncture mechanism of AD, implying that acupuncture may modulate these associated networks.

Strengths and weaknesses

To our knowledge, previous systematic reviews have focused on the efficacy and safety of acupuncture for AD. This is the first systematic review to explore the acupuncture mechanism for AD. Moreover, this review may provide specific insights into the neurocentral mechanism of acupuncture in AD subjects by summarizing the findings of recent clinical neuroimaging studies. In addition, the review was registered in PROSPERO and followed the PRISMA and AMSTAR-2 statement to improve the reporting and methodological quality. Nonetheless, this review had several limitations. First, the studies included used multiple analytical imaging approaches; therefore, quantitative meta-analyses were impossible. Furthermore, while 13 studies were included, only one was an RCT, and the others were non-RCTs, indicating low evidence. Due to the small sample size of the included studies, the findings are potentially biased. Moreover, the included studies only focused on the effects of instant acupuncture. Nevertheless, while the instant effect of acupuncture is still important to consider, the constant acupuncture effect must be explored. Finally, acupuncture has not only been used in clinical practice but is usually combined with other therapies for AD; accordingly, studies that investigate the mechanism of acupuncture combined with other therapies for AD should be conducted in the future.

Conclusion

This review indicates that acupuncture for AD involves brain regions in cognitive- and motor-associated networks, especially in the cingulate gyrus, middle frontal gyrus, and cerebellum. However, these findings remain in the preliminary exploration stage. Larger, well-designed, long-term trials with multimodal neuroimaging techniques need to be conducted to confirm the neuroimaging findings.

Availability of data and materials

All data generated or analysed during this study are included in this article.

References

  1. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. Alzheimer's disease. Lancet. 2021;397(10284):1577–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Joe E, Ringman JM. Cognitive symptoms of Alzheimer's disease: clinical management and prevention. BMJ. 2019;367:l6217.

    Article  PubMed  Google Scholar 

  3. Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer's disease. Lancet. 2016;388(10043):505–17.

    Article  CAS  PubMed  Google Scholar 

  4. Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis. J Affect Disord. 2016;190:264–71.

    Article  PubMed  Google Scholar 

  5. Rocca P, Leotta D, Liffredo C, Mingrone C, Sigaudo M, Capellero B, et al. Neuropsychiatric symptoms underlying caregiver stress and insight in Alzheimer's disease. Dement Geriatr Cogn Disord. 2010;30(1):57–63.

    Article  PubMed  Google Scholar 

  6. Depypere H, Vierin A, Weyers S, Sieben A. Alzheimer's disease, apolipoprotein E and hormone replacement therapy. Maturitas. 2016;94:98–105.

    Article  CAS  PubMed  Google Scholar 

  7. Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer's disease. Arch Med Res. 2012;43(8):600–8.

    Article  PubMed  Google Scholar 

  8. Fiest KM, Roberts JI, Maxwell CJ, Hogan DB, Smith EE, Frolkis A, et al. The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis. Can J Neurol Sci. 2016;43(Suppl 1):S51–82.

    Article  PubMed  Google Scholar 

  9. Battle DE. Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas. 2013;25(2):191–2.

    PubMed  Google Scholar 

  10. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010;362(4):329–44.

    Article  CAS  PubMed  Google Scholar 

  11. 2022 Alzheimer's disease facts and figures. Alzheimers Dement. 2022;18(4):700-89.

  12. Cummings JL, Tong G, Ballard C. Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options. J Alzheimers Dis. 2019;67(3):779–94.

    Article  PubMed  PubMed Central  Google Scholar 

  13. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CJ, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kumar A, Mehta V, Raj U, Varadwaj PK, Udayabanu M, Yennamalli RM, et al. Computational and In-Vitro Validation of Natural Molecules as Potential Acetylcholinesterase Inhibitors and Neuroprotective Agents. Curr Alzheimer Res. 2019;16(2):116–27.

    Article  CAS  PubMed  Google Scholar 

  15. Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease. Neuropharmacology. 2021;190:108352.

    Article  CAS  PubMed  Google Scholar 

  16. Morris R, Luboff H, Jose RP, Eckhoff K, Bu K, Pham M, et al. Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System. J Alzheimers Dis. 2021;81(1):297–307.

    Article  CAS  PubMed  Google Scholar 

  17. Turon-Estrada A, López-Pousa S, Gelada-Batlle E, Garre-Olmo J, Lozano-Gallego M, Hernández-Ferràndiz M, et al. Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period. Rev Neurol. 2003;36(5):421–4.

    CAS  PubMed  Google Scholar 

  18. Peng WN, Zhao H, Liu ZS, Wang S. Acupuncture for vascular dementia. Cochrane Database Syst Rev. 2007;2007(2):D4987.

    Google Scholar 

  19. He W, Li M, Han X, Zhang W. Acupuncture for mild cognitive impairment and dementia: an overview of systematic reviews. Front Aging Neurosci. 2021;13:647629.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Chen Y, Wang H, Sun Z, Su X, Qin R, Li J, et al. Effectiveness of acupuncture for patients with vascular dementia: a systematic review and meta-analysis. Complement Ther Med. 2022;70:102857.

    Article  PubMed  Google Scholar 

  21. Kwon CY, Lee B, Suh HW, Chung SY, Kim JW. Efficacy and safety of auricular acupuncture for cognitive impairment and dementia: a systematic review. Evid Based Complement Alternat Med. 2018;2018:3426078.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lee MS, Shin BC, Ernst E. Acupuncture for Alzheimer's disease: a systematic review. Int J Clin Pract. 2009;63(6):874–9.

    Article  CAS  PubMed  Google Scholar 

  23. Huang Q, Luo D, Chen L, Liang FX, Chen R. Effectiveness of acupuncture for Alzheimer's disease: an updated systematic review and meta-analysis. Curr Med Sci. 2019;39(3):500–11.

    Article  CAS  PubMed  Google Scholar 

  24. Wang YY, Yu SF, Xue HY, Li Y, Zhao C, Jin YH. Effectiveness and safety of acupuncture for the treatment of alzheimer's disease: a systematic review and meta-analysis. Front Aging Neurosci. 2020;12:98.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Zhou S, Dong L, He Y, Xiao H. Acupuncture plus herbal medicine for Alzheimer's disease: a systematic review and meta-analysis. Am J Chin Med. 2017;45(7):1327–44.

    Article  PubMed  Google Scholar 

  26. Jia Y, Zhang X, Yu J, Han J, Yu T, Shi J, et al. Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial. BMC Complement Altern Med. 2017;17(1):556.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Xia KP, Pang J, Li SL, Zhang M, Li HL, Wang YJ. Effect of electroacupuncture at governor vessel on learning-memory ability and serum level of APP, Aβ(1-42) in patients with Alzheimer's disease. Zhongguo Zhen Jiu. 2020;40(4):375–8.

    PubMed  Google Scholar 

  28. Yin Z, Li X, Wang L, Sun M, Zhao L, Liang F. The comparative efficacy of multiple acupuncture for Alzheimer's disease: a bayesian network meta-analysis. Evid Based Complement Alternat Med. 2022;2022:3288948.

    PubMed  PubMed Central  Google Scholar 

  29. Monzio CG, Di Fonzo A, Corti S, Comi GP, Bresolin N, Masliah E. The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer's disease and Parkinson's disease. Mol Neurobiol. 2020;57(7):2959–80.

    Article  Google Scholar 

  30. Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurol. 2020;19(11):951–62.

    Article  PubMed  Google Scholar 

  31. Fitzpatrick A, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, et al. Cryo-EM structures of tau filaments from Alzheimer's disease. Nature. 2017;547(7662):185–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Zhan Y, Fu Q, Pei J, Fan M, Yu Q, Guo M, et al. Modulation of brain activity and functional connectivity by acupuncture combined with donepezil on mild-to-moderate Alzheimer's disease: a neuroimaging pilot study. Front Neurol. 2022;13:912923.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Yu CC, Ma CY, Wang H, Kong LH, Zhao Y, Shen F, et al. Effects of acupuncture on Alzheimer's disease: evidence from neuroimaging studies. Chin J Integr Med. 2019;25(8):631–40.

    Article  PubMed  Google Scholar 

  34. Zheng W, Su Z, Liu X, Zhang H, Han Y, Song H, et al. Modulation of functional activity and connectivity by acupuncture in patients with Alzheimer disease as measured by resting-state fMRI. PLoS One. 2018;13(5):e196933.

    Article  Google Scholar 

  35. Liang P, Wang Z, Qian T, Li K. Acupuncture stimulation of Taichong (Liv3) and Hegu (LI4) modulates the default mode network activity in Alzheimer's disease. Am J Alzheimers Dis Other Dement. 2014;29(8):739–48.

    Article  Google Scholar 

  36. Wang Z, Liang P, Zhao Z, Han Y, Song H, Xu J, et al. Acupuncture modulates resting state hippocampal functional connectivity in Alzheimer disease. PLoS One. 2014;9(3):e91160.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Jia B, Liu Z, Min B, Wang Z, Zhou A, Li Y, et al. The effects of acupuncture at real or sham acupoints on the intrinsic brain activity in mild cognitive impairment patients. Evid Based Complement Alternat Med. 2015;2015:529675.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Sterne J, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

    Article  PubMed  Google Scholar 

  41. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Ji S, Zhang H, Qin W, Liu M, Zheng W, Han Y, et al. Effect of Acupuncture Stimulation of Hegu (LI4) and Taichong (LR3) on the Resting-State Networks in Alzheimer's Disease: Beyond the Default Mode Network. Neural Plast. 2021;2021:8876873.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Shan Y, Wang J, Wang Z, Zhao Z, Zhang M, Xu J, et al. Neuronal Specificity of Acupuncture in Alzheimer's Disease and Mild Cognitive Impairment Patients: A Functional MRI Study. Evid Based Complement Alternat Med. 2018;2018:7619197.

  44. Wang Z, Nie B, Li D, Zhao Z, Han Y, Song H, et al. Effect of acupuncture in mild cognitive impairment and Alzheimer disease: a functional MRI study. PLoS One. 2012;7(8):e42730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Zhou Y, Jin J. Effect of acupuncture given at the HT 7, ST 36, ST 40 and KI 3 acupoints on various parts of the brains of Alzheimer' s disease patients. Acupunct Electrother Res. 2008;33(1-2):9–17.

    Article  PubMed  Google Scholar 

  46. Fu P. Effect of electroacupuncture stimulation on brain functional magnetic resonance imaging in Alzheimer's disease. Doctor.: Capital Medical University; 2006.

  47. Yan B. Study of acupuncture in healthy and Alzheimer's disease persons using functional magnetic resonance imaging. Doctor.: Institute of High Energy Physics of the Chinese Academy of Sciences; 2005.

  48. Wang W. Brain fMRI series study on the mechanism of acupuncture at "Siguan point" in the treatment of Alzheimer's disease. Doctor: Capital Medical University; 2005.

  49. Fu P, Jia J, Zhu J, Huang J. Effects of acupuncture at Neiguan (PC 6) on human brain functional imaging in different functional states. Zhongguo Zhen Jiu. 2005;25(11):784–6.

    PubMed  Google Scholar 

  50. Fu P, Jia J, Min B. Effect of acupuncture at Neiguan point on brain functional magnetic resonance imaging in Alzheimer's disease. Chin J Neurol. 2005;02:118–9.

    Google Scholar 

  51. Fu P, Jia J, Wang M. Acupuncture at shenmen acupoint for brain functional MRI of patients with Alzheimer's disease. Chin J Clin Rehabil. 2005;01:120–1.

    Google Scholar 

  52. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734–46.

    Article  PubMed  Google Scholar 

  53. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. J Evid Based Med. 2010;3(3):140–55.

    Article  PubMed  Google Scholar 

  54. Moayedi M, Salomons TV, Atlas LY. Pain Neuroimaging in Humans: A Primer for Beginners and Non-Imagers. J Pain. 2018;19(9):961.

    Article  PubMed Central  Google Scholar 

  55. Scheyer O, Rahman A, Hristov H, Berkowitz C, Isaacson RS, Diaz BR, et al. Female Sex and Alzheimer's Risk: The Menopause Connection. J Prev Alzheimers Dis. 2018;5(4):225–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Pike CJ. Sex and the development of Alzheimer's disease. J Neurosci Res. 2017;95(1-2):671–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Li R, Singh M. Sex differences in cognitive impairment and Alzheimer's disease. Front Neuroendocrinol. 2014;35(3):385–403.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Kang Z, Ye H, Chen T, Zhang P. Effect of Electroacupuncture at Siguan Acupoints on Expression of BDNF and TrkB Proteins in the Hippocampus of Post-Stroke Depression Rats. J Mol Neurosci. 2021;71(10):2165–71.

    Article  CAS  PubMed  Google Scholar 

  59. Hu NJ, Liu YQ, Zhao MY, Wang P, Wu GW, Hu SQ, et al. Influence of the intensity, components, and spreading of the deqi sensation on the analgesic effect of sp6 needling in primary dysmenorrhea patients: a secondary analysis of a randomised controlled trial. Evid Based Complement Alternat Med. 2019;2019:6462576.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Si X, Han S, Zhang K, Zhang L, Sun Y, Yu J, et al. The temporal dynamics of EEG microstate reveals the neuromodulation effect of acupuncture with Deqi. Front Neurosci. 2021;15:715512.

    Article  PubMed  PubMed Central  Google Scholar 

  61. McLennan SN, Mathias JL, Brennan LC, Stewart S. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol. 2011;24(1):33–8.

    Article  CAS  PubMed  Google Scholar 

  62. Can H, Doğutepe E, Torun YN, Korkman H, Erdoğan BE. Construct validity of auditory verbal learning test. Turk Psikiyatri Derg. 2016;27(3):195–203.

    PubMed  Google Scholar 

  63. Jiang Y, Yang H, Zhao J, Wu Y, Zhou X, Cheng Z. Reliability and concurrent validity of Alzheimer's disease assessment scale - Cognitive subscale, Chinese version (ADAS-Cog-C) among Chinese community-dwelling older people population. Clin Neuropsychol. 2020;34(sup1):43–53.

    Article  PubMed  Google Scholar 

  64. Kueper JK, Speechley M, Montero-Odasso M. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review. J Alzheimers Dis. 2018;63(2):423–44.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Cardenas DP, Muir ER, Huang S, Boley A, Lodge D, Duong TQ. Functional MRI during hyperbaric oxygen: Effects of oxygen on neurovascular coupling and BOLD fMRI signals. NeuroImage. 2015;119:382–9.

    Article  PubMed  Google Scholar 

  66. Khan S, Barve KH, Kumar MS. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. Curr Neuropharmacol. 2020;18(11):1106–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Holtzman DM, Mandelkow E, Selkoe DJ. Alzheimer disease in 2020. Cold Spring Harb Perspect Med. 2012;2(11):a011585.

  69. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137–52.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Stěpán-Buksakowska I, Keller J, Laczó J, Rulseh A, Hort J, Lisý J, et al. Diffusion tensor imaging in Alzheimer disease and mild cognitive impairment. Neurol Neurochir Pol. 2012;46(5):462–71.

    Article  PubMed  Google Scholar 

  71. Claus JJ, Ongerboer DVB, Walstra GJ, Hijdra A, Verbeeten BJ, van Gool WA. Quantitative spectral electroencephalography in predicting survival in patients with early Alzheimer disease. Arch Neurol. 1998;55(8):1105–11.

    Article  CAS  PubMed  Google Scholar 

  72. Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, et al. Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol. 2021;78(8):961–71.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Guerrier L, Le Men J, Gane A, Planton M, Salabert AS, Payoux P, et al. Involvement of the cingulate cortex in anosognosia: a multimodal neuroimaging study in Alzheimer's disease patients. J Alzheimers Dis. 2018;65(2):443–53.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Bailly M, Destrieux C, Hommet C, Mondon K, Cottier JP, Beaufils E, et al. Precuneus and cingulate cortex atrophy and hypometabolism in patients with alzheimer's disease and mild cognitive impairment: MRI and (18)F-FDG PET quantitative analysis using freesurfer. Biomed Res Int. 2015;2015:583931.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Zhang Q, Wang Q, He C, Fan D, Zhu Y, Zang F, et al. Altered regional cerebral blood flow and brain function across the Alzheimer's disease spectrum: a potential biomarker. Front Aging Neurosci. 2021;13:630382.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Snowden SG, Ebshiana AA, Hye A, Pletnikova O, O'Brien R, Yang A, et al. Neurotransmitter imbalance in the brain and Alzheimer's disease pathology. J Alzheimers Dis. 2019;72(1):35–43.

    Article  CAS  PubMed  Google Scholar 

  77. Mao Y, Liao Z, Liu X, Li T, Hu J, Le D, et al. Disrupted balance of long and short-range functional connectivity density in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients: a resting-state fMRI study. Ann Transl Med. 2021;9(1):65.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Gellersen HM, Guell X, Sami S. Differential vulnerability of the cerebellum in healthy ageing and Alzheimer's disease. Neuroimage Clin. 2021;30:102605.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Zhou Z, Zhu R, Shao W, Zhang SJ, Wang L, Ding XJ, et al. Changes in resting-state functional connectivity of cerebellum in amnestic mild cognitive impairment and Alzheimer's disease: a case-control study. Front Syst Neurosci. 2021;15:596221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Jacobs H, Hopkins DA, Mayrhofer HC, Bruner E, van Leeuwen FW, Raaijmakers W, et al. The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline. Brain. 2018;141(1):37–47.

    Article  PubMed  Google Scholar 

  81. Larner AJ. The cerebellum in Alzheimer's disease. Dement Geriatr Cogn Disord. 1997;8(4):203–9.

    Article  CAS  PubMed  Google Scholar 

  82. Greene SJ, Killiany RJ. Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease. Neurobiol Aging. 2010;31(8):1304–11.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Kim JH, Lee JW, Kim GH, Roh JH, Kim MJ, Seo SW, et al. Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer's disease. Neurobiol Aging. 2012;33(9):1959–66.

    Article  PubMed  Google Scholar 

  84. Yan S, Zheng C, Cui B, Qi Z, Zhao Z, An Y, et al. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2020;47(10):2440–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Putcha D, Dickerson BC, Brickhouse M, Johnson KA, Sperling RA, Papp KV. Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum. Neuropsychologia. 2020;140:107391.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Valera-Bermejo JM, De Marco M, Mitolo M, McGeown WJ, Venneri A. Neuroanatomical and cognitive correlates of domain-specific anosognosia in early Alzheimer's disease. Cortex. 2020;129:236–46.

    Article  PubMed  Google Scholar 

  87. Prawiroharjo P, Yamashita KI, Yamashita K, Togao O, Hiwatashi A, Yamasaki R, et al. Disconnection of the right superior parietal lobule from the precuneus is associated with memory impairment in oldest-old Alzheimer's disease patients. Heliyon. 2020;6(7):e4516.

    Article  Google Scholar 

  88. Zhou B, Liu Y, Zhang Z, An N, Yao H, Wang P, et al. Impaired functional connectivity of the thalamus in Alzheimer's disease and mild cognitive impairment: a resting-state fMRI study. Curr Alzheimer Res. 2013;10(7):754–66.

    Article  CAS  PubMed  Google Scholar 

  89. Wu QJ, Guo ZJ, Liu SE, Yu HQ, Chen J, Yang HM. Relationship between episodic memory and resting-state brain functional connectivity network in patients with Alzheimer's disease and mild cognition impairment. Zhonghua Yi Xue Za Zhi. 2013;93(23):1795–800.

    PubMed  Google Scholar 

  90. Feng F, Huang W, Meng Q, Hao W, Yao H, Zhou B, et al. Altered volume and structural connectivity of the hippocampus in Alzheimer's Disease and Amnestic Mild Cognitive Impairment. Front Aging Neurosci. 2021;13:705030.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Li F, Liu M. A hybrid convolutional and recurrent neural network for hippocampus analysis in Alzheimer's disease. J Neurosci Methods. 2019;323:108–18.

    Article  PubMed  Google Scholar 

  92. Lu J, Testa N, Jordan R, Elyan R, Kanekar S, Wang J, et al. Functional connectivity between the resting-state olfactory network and the Hippocampus in Alzheimer's Disease. 2019;9(12):338.

  93. Chen S, Xu M, Li H, Liang J, Yin L, Liu X, et al. Acupuncture at the Taixi (KI3) acupoint activates cerebral neurons in elderly patients with mild cognitive impairment. Neural Regen Res. 2014;9(11):1163–8.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Liu H, Chen L, Zhang G, Jiang Y, Qu S, Liu S, et al. Scalp acupuncture enhances the functional connectivity of visual and cognitive-motor function network of patients with acute ischemic stroke. Evid Based Complement Alternat Med. 2020;2020:8836794.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Liu Z, Wei W, Bai L, Dai R, You Y, Chen S, et al. Exploring the patterns of acupuncture on mild cognitive impairment patients using regional homogeneity. PLoS One. 2014;9(6):e99335.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Wang XR, Shi GX, Yang JW, Yan CQ, Lin LT, Du SQ, et al. Acupuncture ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia through Nrf2-mediated antioxidant response. Free Radic Biol Med. 2015;89:1077–84.

    Article  CAS  PubMed  Google Scholar 

  97. Li G, Zhang X, Cheng H, Shang X, Xie H, Zhang X, et al. Acupuncture improves cognitive deficits and increases neuron density of the hippocampus in middle-aged SAMP8 mice. Acupunct Med. 2012;30(4):339–45.

    Article  PubMed  Google Scholar 

  98. Liu CZ, Yu JC, Zhang XZ, Fu WW, Wang T, Han JX. Acupuncture prevents cognitive deficits and oxidative stress in cerebral multi-infarction rats. Neurosci Lett. 2006;393(1):45–50.

    Article  CAS  PubMed  Google Scholar 

  99. Xiao LY, Wang XR, Yang Y, Yang JW, Cao Y, Ma SM, et al. Applications of acupuncture therapy in modulating plasticity of central nervous system. Neuromodulation. 2018;21(8):762–76.

    Article  PubMed  Google Scholar 

  100. Liu CZ, Kong J, Wang K. Acupuncture therapies and neuroplasticity. Neural Plast. 2017;2017:6178505.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Guan Z, Zhang M, Zhang Y, Li B, Li Y. Distinct Functional and Metabolic Alterations of DMN Subsystems in Alzheimer's Disease: A Simultaneous FDG-PET/fMRI Study. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:3443–6.

    PubMed  Google Scholar 

  102. Lee JS, Kim JH, Lee SK. The relationship between neuropsychiatric symptoms and default-mode network connectivity in Alzheimer's Disease. Psychiatry Investig. 2020;17(7):662–6.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Dennis EL, Thompson PM. Functional brain connectivity using fMRI in aging and Alzheimer's disease. Neuropsychol Rev. 2014;24(1):49–62.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Daigle KM, Pietrzykowski MO, Waters AB, Swenson LP, Gansler DA. Central executive network and executive function in patients with Alzheimer's disease and healthy individuals: meta-analysis of structural and functional MRI. J Neuropsychiatry Clin Neurosci. 2022;34(3):204–13.

    Article  PubMed  Google Scholar 

  105. Kim HJ, Cha J, Lee JM, Shin JS, Jung NY, Kim YJ, et al. Distinctive resting state network disruptions among Alzheimer's disease, subcortical vascular dementia, and mixed dementia patients. J Alzheimers Dis. 2016;50(3):709–18.

    Article  PubMed  Google Scholar 

  106. Yamashita KI, Uehara T, Taniwaki Y, Tobimatsu S, Kira JI. Long-term effect of acetylcholinesterase inhibitors on the dorsal attention network of Alzheimer's disease patients: a pilot study using resting-state functional magnetic resonance imaging. Front Aging Neurosci. 2022;14:810206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Zhan Y, Ma J, Alexander-Bloch AF, Xu K, Cui Y, Feng Q, et al. Longitudinal study of impaired intra- and inter-network brain connectivity in subjects at high risk for Alzheimer's disease. J Alzheimers Dis. 2016;52(3):913–27.

    Article  CAS  PubMed  Google Scholar 

  108. Qian S, Zhang Z, Li B, Sun G. Functional-structural degeneration in dorsal and ventral attention systems for Alzheimer's disease, amnestic mild cognitive impairment. Brain Imaging Behav. 2015;9(4):790–800.

    Article  PubMed  Google Scholar 

  109. Wang J, Liu J, Wang Z, Sun P, Li K, Liang P. Dysfunctional interactions between the default mode network and the dorsal attention network in subtypes of amnestic mild cognitive impairment. Aging (Albany NY). 2019;11(20):9147–66.

    Article  PubMed  Google Scholar 

  110. Zhao Q, Sang X, Metmer H, Swati Z, Lu J. Functional segregation of executive control network and frontoparietal network in Alzheimer's disease. Cortex. 2019;120:36–48.

    Article  PubMed  Google Scholar 

  111. Zhao Q, Lu H, Metmer H, Li W, Lu J. Evaluating functional connectivity of executive control network and frontoparietal network in Alzheimer's disease. Brain Res. 2018;1678:262–72.

    Article  CAS  PubMed  Google Scholar 

  112. Li B, Zhang M, Jang I, Ye G, Zhou L, He G, et al. Amyloid-Beta Influences Memory via Functional Connectivity During Memory Retrieval in Alzheimer's Disease. Front Aging Neurosci. 2021;13:721171.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Tumati S, Marsman JC, De Deyn PP, Martens S, Aleman A. Functional network topology associated with apathy in Alzheimer's disease. J Affect Disord. 2020;266:473–81.

    Article  PubMed  Google Scholar 

  114. Agosta F, Rocca MA, Pagani E, Absinta M, Magnani G, Marcone A, et al. Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp. 2010;31(4):515–25.

    PubMed  Google Scholar 

  115. Hsiao FJ, Chen WT, Wang YJ, Yan SH, Lin YY. Altered source-based EEG coherence of resting-state sensorimotor network in early-stage Alzheimer's disease compared to mild cognitive impairment. Neurosci Lett. 2014;558:47–52.

    Article  CAS  PubMed  Google Scholar 

  116. Ramírez-Toraño F, Bruña R, de Frutos-Lucas J, Rodríguez-Rojo IC, Marcos DPS, Delgado-Losada ML, et al. Functional connectivity hypersynchronization in relatives of Alzheimer's disease patients: an early E/I balance dysfunction? Cereb Cortex. 2021;31(2):1201–10.

    Article  PubMed  Google Scholar 

  117. Tang F, Zhu D, Ma W, Yao Q, Li Q, Shi J. Differences changes in cerebellar functional connectivity between mild cognitive impairment and Alzheimer's disease: a seed-based approach. Front Neurol. 2021;12:645171.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Zhang J, Lu C, Wu X, Nie D, Yu H. Neuroplasticity of acupuncture for stroke: an evidence-based review of MRI. Neural Plast. 2021;2021:2662585.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Zhang Y, Zhang H, Nierhaus T, Pach D, Witt CM, Yi M. Default mode network as a neural substrate of acupuncture: evidence, Challenges and Strategy. Front Neurosci. 2019;13:100.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Dhond RP, Yeh C, Park K, Kettner N, Napadow V. Acupuncture modulates resting state connectivity in default and sensorimotor brain networks. Pain. 2008;136(3):407–18.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Zhao T, Pei L, Ning H, Guo J, Song Y, Zhou J, et al. Networks are associated with acupuncture treatment in patients with diarrhea-predominant irritable bowel syndrome: a resting-state imaging study. Front Hum Neurosci. 2021;15:736512.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Bai L, Qin W, Tian J, Dong M, Pan X, Chen P, et al. Acupuncture modulates spontaneous activities in the anticorrelated resting brain networks. Brain Res. 2009;1279:37–49.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Home for Researchers editorial team (www.home-forresearchers.com) and Editage (www.editage.cn) for language editing service.

Funding

This work was financially supported by the State Administration of Traditional Chinese Medicine, and National Natural Science Foundation of China (no. 81590951, 82004486, 81722050, 81973961, 82201628).

Author information

Author notes

  1. Zihan Yin, Ziqi Wang and Yaqin Li contributed equally to this work and share first authorship.

Authors and Affiliations

  1. School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    Zihan Yin, Yaqin Li, Jun Zhou, Zhenghong Chen, Manze Xia, Xinyue Zhang, Ling Zhao & Fanrong Liang

  2. Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China

    Zihan Yin, Zhenghong Chen, Manze Xia, Xinyue Zhang, Ling Zhao & Fanrong Liang

  3. the Fourth People’s Hospital of Chengdu, Chengdu, China

    Ziqi Wang

  4. School of Nursing, Zunyi Medical University, Zunyi, China

    Jiajing Wu

Authors
  1. Zihan Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ziqi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yaqin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhenghong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Manze Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xinyue Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jiajing Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ling Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fanrong Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Zihan Yin, Ling Zhao, and Fanrong Liang provided the concept and design. Zihan Yin and Xinyue Zhang provided the analysis plan and performed analysis. Manze Xia and Zhenghong Chen performed study search, screening, and extraction of data, whereas Yaqin Li and Jiajing Wu reviewed the work. Zihan Yin, Ziqi Wang, and Yaqin Li wrote the first draft of the current review, with Jun Zhou, Ling Zhao and Fanrong Liang provided input to the final draft. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Ling Zhao or Fanrong Liang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Search strategies of each database.

Additional file 2.

Full-text articles excluded with reasons.

Additional file 3.

Methodological quality assessments of randomised studies of the effects of interventions using RoB 2.

Additional file 4.

Methodological quality assessments of non-randomised studies of the effects of interventions using ROBINS-I.

Additional file 5.

Neuroimaging results after acupuncture.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yin, Z., Wang, Z., Li, Y. et al. Neuroimaging studies of acupuncture on Alzheimer’s disease: a systematic review. BMC Complement Med Ther 23, 63 (2023). https://doi.org/10.1186/s12906-023-03888-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-023-03888-y

Keywords

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us